Geographic · Other long-lived assets
Europe — Other long-lived assets
Biogen Europe — Other long-lived assets decreased by 4.0% to $2.05B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.0%, from $2.14B to $2.05B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025
Rolls up toPP&E (Net)
How to read this metric
An increase suggests capital investment or expansion in European markets outside of Germany, while a decrease may indicate asset depreciation, divestiture, or impairment.
Detailed definition
This metric represents the net book value of non-current, tangible, and intangible assets held by the company within its...
Peer comparison
Peers typically report long-lived assets by major geographic region; this metric is comparable to regional property, plant, and equipment (PP&E) disclosures in international segment reporting.
Metric ID:
biib_segment_europe_other_long_lived_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.34B | $2.28B | $2.25B | $2.14B | $2.05B |
| QoQ Change | — | -2.7% | -1.2% | -4.8% | -4.0% |
| YoY Change | — | -2.7% | -1.2% | -4.8% | -4.0% |
Range$2.05B – $2.34B
CAGR-12.1%
Avg YoY Growth-3.2%
Median YoY Growth-3.3%
Current Streak4+ quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's europe — other long-lived assets?
- Biogen (BIIB) reported europe — other long-lived assets of $2.05B in Q4 2025.
- How has Biogen's europe — other long-lived assets changed year-over-year?
- Biogen's europe — other long-lived assets decreased by 4.0% year-over-year, from $2.14B to $2.05B.
- What does europe — other long-lived assets mean?
- The total value of the company's long-term assets located in Europe, excluding those in Germany.